4.7 Article

Downregulated USP3 mRNA functions as a competitive endogenous RNA of SMAD4 by sponging miR-224 and promotes metastasis in colorectal cancer

期刊

SCIENTIFIC REPORTS
卷 7, 期 -, 页码 -

出版社

NATURE PORTFOLIO
DOI: 10.1038/s41598-017-04368-3

关键词

-

资金

  1. National Natural Science Foundation of China [81272766, 81450028, 81672439, 81470129, 81402346, 81502137]
  2. National High Technology Research and Development Program of China (863 Program) [2014AA020603]
  3. Beijing Natural Science Foundation [7162039, 7132054, 7172042]
  4. Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support [XM201309]
  5. Peking University (PKU) 985 Special Funding for Collaborative Research with PKU Hospitals
  6. Beijing Municipal Administration of Hospitals Incubating Program [PX2016018]
  7. Beijing Health System High-level Health Technical Personnel Training Program [2015-3-074]
  8. Excellent Overseas-Returnee Scholar Program (Ministry of Education)

向作者/读者索取更多资源

Increasing evidence shows that competitive endogenous RNAs (ceRNAs) can affect the expression of other transcripts by sequestering common microRNAs (miRNAs), and participate in tumourigenesis. As a potent tumour suppressor in colorectal cancer (CRC), SMAD4 is regulated by many miRNAs. However, the regulation of SMAD4 by ceRNAs has never been examined. In the present study, we found that USP3 modulated SMAD4 expression in a miRNA dependent, and protein-coding gene independent manner. USP3 and SMAD4 were directly targeted by miR-224, and overexpression of the USP3 3'UTR could inhibit metastasis caused by the loss of USP3. The correlation of USP3, SMAD4 and miR-224 expression was further verified in CRC specimens. Additionally, the loss of USP3 was associated with distal metastasis and a poor prognosis. Altogether, our study demonstrates USP3 as a bona fide SMAD4 ceRNA. The results from this study may provide new insights into the prevention and treatment of CRC.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据